News der Mitglieder

10.07.2019Georg Lentzen as New Managing Director of b.value AG appointed
Dr. Georg Lentzen has been appointed as Managing Director of b.value AG as of 01.07.2019. Dr. Lentzen brings in-depth expertise and knowledge of biotechnological processes, and their commercialisation in young companies, to accelerate the positive development of b.value AG.

Dr. Lentzen comes with over 20 years of experience in various leadership roles in biotech companies in the United Kingdom, Germany and The Netherlands. Prior to joining b.value AG, Dr. Lentzen was Director R&D at the Dutch biotech company Isobionics B.V. where he coordinated the development of a biotech platform for terpene-based flavour and fragrance products. Earlier in his career, he was responsible for R&D at bitop AG (Germany) and led a team in drug discovery at Vernalis plc (UK). Dr. Lentzen received a PhD in biochemistry from the University Witten/Herdecke.

At the same time, Dr. Thomas Schwarz is leaving the management team of the b.value AG. He will continue to support the company as shareholder and ideas provider.


CLIB2021 @ Twitter CLIB2021 @ Google+ CLIB2021 @ XING